Evidence regarding pain in ATP13A2 pathogenic variants is limited and insufficient.

Genetic_Association Score: 0.500 Price: $0.50 Parkinson's disease human Status: extracted

What This Experiment Tests

Genetic_Association experiment designed to assess clinical efficacy targeting ATP13A2 in human. Primary outcome: Evidence regarding pain in ATP13A2 pathogenic variants is limited and insufficient.

Description

Insufficient data from systematic review

TARGET GENE

ATP13A2

MODEL SYSTEM

human

ESTIMATED COST

TIMELINE

0 months

PATHWAY

null

SOURCE

pmid_38020640

PRIMARY OUTCOME

Evidence regarding pain in ATP13A2 pathogenic variants is limited and insufficient.

Scoring Dimensions

Related Hypotheses (1)

Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate0.749

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.